Skip to main content

Table 1 Characteristics of elderly patients with hepatocellular carcinoma

From: Effect of timing of surgical resection of primary hepatocellular carcinoma on survival outcomes in elderly patients and prediction of clinical models

Variables Overall (N = 232)
Age* 62 (64–67.8)
Sex  
Male 174 (75%)
Female 58 (25%)
BMI* 22.7 (20.6–24.8)
Smoking  
Yes 69 (27.9%)
No 163 (70.3%)
Alcohol  
Yes 66 (28.4%)
No 166 (71.6%)
Diabetes  
Yes 34 (14.7%)
No 198 (85.3%)
BCLC stage  
0–A stage 190 (81.9%)
B–C stage 42 (18.1%)
Child-Pugh  
Grade A 222 (95.7%)
Grade B 10 (4.3%)
Liver cirrhosis  
Yes 108 (46.6%)
No 124 (53.4%)
Liver fluke  
Yes 22 (9.5%)
No 210 (90.5%)
Viral hepatitis B  
Yes 161 (69.4%)
No 71 (30.6%)
Viral hepatitis C  
Yes 9 (3.9%)
No 223 (96.1%)
AFP, ng/mL  
≤ 8 65 (28%)
>8 167 (72%)
Tumor number  
Single 202 (87.1%)
Multiple 30 (12.9%)
Tumor size, cm  
<5 132 (56.9%)
≥ 5 100 (43.1%)
Venous tumor emboli  
Yes 28 (12.1%)
No 204 (87.9%)
Time of operation* 240 (172–296)
Bleeding* 350 (200–600)
Local chemotherapy  
Yes 73 (31.5%)
No 159 (68.5%)
Radical resection  
Yes 139 (59.5%)
No 94 (40.5%)
Laparoscopic hepatectomy  
Yes 54 (23.3%)
No 178 (76.7%)
Differentiated degree  
High 14 (6%)
Middle 205 (88.4%)
Low 13 (5.6%)
Microvascular invasion  
Yes 64 (27.6%)
No 168 (72.4%)
Length of stay* 18 (14–22)
Clavien–Dindo  
I and II 226 (97.4%)
III, IV and V 6 (2.6%)
Overall survival* 37 (23.4–57.6)
Survival status  
Alive 184 (79.3%)
Death 48 (20.7%)
Recurrence  
Yes 69 (29.7%)
No 163 (70.3%)
TTS* 18 (14–29.8)
  1. *Median (IQR).AFP indicates alpha-fetoprotein;BMI, body-mass index;IQR, interquartile range